Thoughts on Scott Gottlieb running the FDA? My initial reaction is 1) He is an advocate for speeding up approval process on generics. This should be motivation for Pharma to bring/buy new technologies from biotech (K, P or
. 2) Orphan Drug designation or anything that lengthens the exclusivity of a new technology becomes more valuable. 3) He shares Trump vison that FDA needs to drastically streamline the overall approval process. I believe this bodes well for CTIX.